Demant
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 a
Tags Tree
Selected: 0
No matching results found.
- Provide an explanation of how your company's greenhouse gas emission reduction targets align with the objective of limiting global warming to 1.5°C, as stipulated by the Paris Agreement, in accordance with Disclosure Requirement E1-1 regarding the transition plan for climate change mitigation.
-
Question Id: E1-1_02
Demant's Transition Plan consolidates the existing climate change mitigation plans and initiatives and details the different mitigation actions set by the Group to reduce the GHG emissions and reach our climate targets aligned with the Paris Agreement. The benchmarks provide a roadmap to ensure that company activities are consistent with the Paris Agreement’s objectives, particularly the goal of limiting the global temperature rise to 1.5°C above pre-industrial levels.
Report Date: 4Q2024Relevance: 85%
- Provide detailed information regarding the types of contractual instruments utilized for the sale and purchase of energy, including those bundled with attributes related to energy generation or for unbundled energy attribute claims. This disclosure should align with the requirements outlined in Disclosure Requirement E1-9, focusing on the anticipated financial effects from material physical and transition risks, as well as potential climate-related opportunities. Ensure that the information adheres to the qualitative characteristics of useful information as specified in ESRS 1 Appendix B. Additionally, when calculating gross Scope 2 GHG emissions, apply both the location-based and market-based methods, and disclose the share and types of contractual instruments accordingly.
-
Question Id: E1-6_23
35% of the Group’s electricity consumption is now covered by renewable sources, mainly from electricity vendors (directly sourced) and Energy Attribute Certificates.
Report Date: 4Q2024Relevance: 50%